A Prospective, Randomized, Multi-centered, Placebo-controlled Clinical Trial of Oral Vanycomycin in Adults With Primary Sclerosing Cholangitis
Phase: PHASE2
Conditions: Primary Sclerosing Cholangitis
Sponsor: Elizabeth Carey

 
 
A Prospective, Randomized, Multi-centered, 
Placebo-controlled, Clinical Trial of Oral 
Vancomycin in Adults with Primary Sclerosing 
Cholangitis 
 
NCT03710122 
 
8November2023 

A Prospective, Randomized, Multi-centered, Placebo-controlled, Clinical Trial of 
Oral Vancomycin in Adults with Primary Sclerosing Cholangitis 
Principal Investigator & 
Regulatory Sponosor: 
Study Product: 
Version: 
Previous Version(s) 
Dr. Elizabeth Carey 
Division of Gastroenterology and Hepatology 
Mayo Clinic Arizona 
5777 E. Mayo Boulevard 
Phoenix, AZ 85054 
(480) 342-1094
Vancomycin Hydrochloride 
Version 3. 6 
November 8, 2023 
List of Changes Since Previous Version: 
•
Changed Pl, as Dr Lindor is now retired
•
Removed ASU as a study site
•
Clarified Individual and Study Stopping criteria
•
Added protocol if patient found to have
received vancomycin outside of the study
Version 1.0 - January 13, 2016 
Version 2.0 - April 26, 2018 
Version 2.1 - July 25, 2018 
Version 3.0 - November 30, 2018 
Version 3.1 - December 20, 2018 
Version 3.2- March 12, 2019 
Version 3.3 - October 23, 2019 
Version 3.4 - February 26, 2020 
Version 3.5 - March 3, 2021 
Version 3.6 - November 8, 2023